Hospital AI Governance: A Practical Framework for Safe Clinical AI

Hospital AI governance has gone from a nice-to-have to an expectation. AI now arrives through many doors: ambient scribes, radiology triage, sepsis scores, chatbots, vendor features switched on in an EMR update, and doctors using general chatbots on their phones. Without governance, a hospital cannot answer basic questions: which AI tools are we using, who approved them, how do we know they work, and what happens when they fail?

Frameworks are now available. In India, ICMR published ethical guidelines for AI in healthcare in 2023, and in February 2026 the Ministry of Health launched SAHI, a national strategy for AI in healthcare, which recommends dedicated AI units in institutions. In the US, the Joint Commission and the Coalition for Health AI (CHAI) released joint guidance on responsible AI use in September 2025.

This guide turns those documents into a practical framework a hospital of any size can run.

What the main frameworks say

The ICMR guidelines set out ten principles, including autonomy, safety and risk minimisation, data privacy, accountability and liability, and non-discrimination and fairness, and call for clinical validation before deployment.

SAHI has 32 recommendations across five pillars. For institutions it recommends dedicated AI units or nodal cells to lead use-case selection, tool assessment, deployment oversight and lifecycle management; clear definitions of human and AI roles with escalation; and role-based AI training. It calls for post-deployment monitoring for performance, bias and drift, and points to the DPDP Act, NHA's Health Data Management Policy and ICMR's guidelines as the legal and ethical base.

The Joint Commission and CHAI guidance lists seven elements: AI policies and governance structures; patient privacy and transparency; data security and data use protections; ongoing quality monitoring; voluntary, blinded reporting of AI safety events; risk and bias assessment; and education and training. It is voluntary, but commentators expect it to shape future accreditation, and the Joint Commission has announced plans for follow-on playbooks and a voluntary certification.

The framework: seven building blocks

1. An AI governance group

Form a small, multi-disciplinary group with authority. In a 100-300 bed hospital this might be the medical director (chair), a senior nurse, the quality and patient safety lead, the IT head, a data or analytics lead, a legal or compliance representative and a clinician who uses AI. Larger groups can follow SAHI's suggestion of a dedicated AI unit.

It meets monthly, approves new AI uses, reviews monitoring reports and incidents, and reports to the hospital's quality committee or board.

2. An AI inventory

You cannot govern what you cannot see. List every AI tool in use or in pilot, including AI features inside vendor products.

Ask department heads directly about informal use, such as staff pasting patient notes into public chatbots. That is a privacy issue under the DPDP Act and needs a clear policy, not just a ban.

3. Risk tiering

Not every tool needs the same scrutiny. A simple three-tier model works:

SAHI treats diagnosis, triage, clinical decision-making and treatment as high-risk, which matches this split.

4. Validation before go-live

For medium and high tiers, require local evidence:

1. A test set from your own patients, including subgroups that matter (age, sex, language, common comorbidities).
2. Shadow-mode running where possible, with no effect on care.
3. Agreed pass criteria set before the test.
4. A bias check: does performance differ across groups?
5. A sign-off memo stored with the inventory entry.

Our guide to evaluating clinical LLMs covers language model testing in detail, and the sepsis early warning guide shows why local validation matters for predictive models.

5. Monitoring after go-live

Models drift as patients, practices and data change. For each medium or high-risk tool, define:

• What is measured: accuracy samples, override rates, alert volumes, edit rates on drafts.
• How often: monthly for high risk, quarterly for medium.
• Who reviews: the tool owner, then the governance group.
• Triggers: thresholds that prompt investigation or suspension.

Vendor updates are a special risk. Require vendors to notify you before model changes and re-run your test set afterwards. In the US, devices with an authorised predetermined change control plan describe planned changes up front; see our AI medical device regulation guide.

6. Incident reporting

Add AI to your existing incident reporting system rather than building a new one. Add a category for AI-related events (wrong output, missed finding, misleading summary, privacy breach) and a field naming the tool. The Joint Commission-CHAI guidance encourages confidential, blinded reporting of AI safety events, similar to other patient safety reporting.

7. Training and transparency

• Staff: role-based training on what each tool does, its limits, and how to override and report. SAHI recommends training scaled to decision-making authority.
• Patients: tell patients when AI is used in ways that affect them, such as ambient recording or AI-drafted messages, and obtain consent where needed.
• Documentation: keep a plain-language fact sheet for each tool.

Vendor contracts

Governance is much easier if contracts support it. Ask for:

• Clear intended use and regulatory status.
• Validation evidence and subgroup performance.
• Advance notice of model updates.
• Access to logs and outputs for audit.
• Data processing terms consistent with the DPDP Act: purpose, retention, location, no training on your data without consent.
• Support for incident investigation.

The data foundation

Every governance step depends on data: logs of inputs and outputs, user actions, outcomes. If your hospital systems cannot record which AI output was shown to whom and what they did, monitoring is guesswork. Building that logging into your hospital management system and AI integrations is a core part of governance, not an afterthought. Algon designs AI features with audit logs and monitoring dashboards from the start; see our AI development services.

Worked example: approving an ambient scribe

Say the cardiology department asks to pilot an ambient AI scribe that listens to consultations and drafts notes. The governance group would work through it like this.

1. Inventory entry. Tool, vendor, intended use (draft OPD notes for doctor sign-off), users, data (consultation audio, patient context), storage location.
2. Risk tier. Medium: it touches clinical records, but every note is reviewed and signed by a doctor.
3. Privacy review. Where is audio processed and stored, and for how long? Is it used for model training? How is patient consent captured, and in which languages? Does the contract meet DPDP Act requirements?
4. Validation plan. Two cardiologists use it on 50 consultations, including Malayalam and mixed-language conversations. Each note is checked for hallucinations and omissions, especially medications and plans, and time per note is compared with the current method.
5. Pass criteria. No high-harm errors, acceptable omission rate, real time saving, and patients rarely declining consent.
6. Go-live conditions. Consent script, visible indicator when recording, one-click problem reporting, monthly sample review for the first six months.
7. Review date. Formal review after three months before expanding to other departments.

Our AI medical scribe guide explains how these tools work and where they fail.

A 90-day starting plan

Mistakes to avoid

• A committee with no authority to pause or stop a tool.
• Governing only new purchases and ignoring AI features switched on in existing software.
• Banning public chatbots without offering a safe internal alternative.
• Validation done once, never repeated after updates.
• Monitoring reports that nobody reads.

Conclusion

Hospital AI governance does not need a large bureaucracy. It needs a group with authority, an honest inventory, risk tiers, local validation, monitoring, incident reporting and training. ICMR's guidelines, India's SAHI strategy and the Joint Commission-CHAI guidance all point the same way, and following them now prepares a hospital for whatever accreditation and regulatory expectations follow.

Start with the inventory. Most hospitals find more AI in use than they expected. For where AI delivers value first, see our guide to AI in hospital management.